Career history of Kristie Wagner
Former positions of Kristie Wagner
| Companies | Position | Start | End |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2013-10-31 | 2021-01-31 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Comptroller/Controller/Auditor | 2021-05-31 | - |
| Director of Finance/CFO | 2022-02-23 | - |
Training of Kristie Wagner
| Suffolk University | Masters Business Admin |
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Kristie Wagner
- Experience
